Liver health roadmaps target hidden disease.
Liver disease carries an unfair reputation as a second-tier health crisis, according to medical specialists meeting in Madrid. The Spanish Association for the Study of the Liver presented two new roadmaps during the Jornadas de Otoño de Salud Hepática held at the Ilustre Colegio Oficial de Médicos de Madrid, as reported by iSanidad.
One in four Spaniards has fatty liver, and nearly three of every ten active hepatitis C infections remain undiagnosed, according to the same reporting. The newly unveiled documents—titled “Las 7 capacidades de un sistema sanitario preparado para abordar la enfermedad hepática metabólica” and “Data to Cure”—seek to improve detection, early diagnosis, and treatment pathways under the broader National Liver Health Plan: Challenge 2032, according to iSanidad.
The hepatitis C virus specifically affects 0.12% of the Spanish population. While 177,276 patients received direct-acting antivirals between 2015 and 2025 with a 94.7% cure rate, gaps in the care cascade persist, iSanidad noted.

Demócrata reported that the framework includes digitalizing the diagnostic algorithm into a single step, enabling prescription and treatment initiation from primary care and community pharmacies rather than hospitals alone, and establishing circuits to start therapy on the very day infection is confirmed.
To connect vulnerable groups, infosalus added that the model proposes generating automated first appointments with specialized care or setting aside dedicated appointment slots in professional schedules.
The second document targets metabolic dysfunction-associated steatotic liver disease, a chronic condition linked to obesity, type 2 diabetes, and cardiovascular risk that affects an estimated 30% of the population, according to Demócrata. infosalus said that the strategy outlines seven core capabilities, beginning with early risk identification through screening programs and automated FIB-4 risk score calculations in routine medical records.
Additional measures include timely fibrosis diagnosis via elastography without delays, coordinated care pathways between primary and specialized medicine, lifestyle support, integrated cardiovascular risk programs, and improved patient information, per iSanidad.
During the presentation, AEEH President Rafael Bañares said that “las enfermedades hepáticas son enfermedades de evolución muy prolongada y esto hace que siempre hayan sido de manera injusta consideradas enfermedades de segunda división”.
Founded in 1967 after a Madrid meeting of 44 physicians convened by Professor Manuel Díaz Rubio, the Spanish Association for the Study of the Liver began as the Spanish Association of Hepatology with a biennial conference schedule.
The society shifted to annual meetings in the 1980s to accelerate scientific exchange, and collaborative research presented at its conferences grew from eleven papers in that decade to ninety-five in the first decade of this century.
The documents were created through co-creation workshops involving scientific societies, social entities, NGOs, and public administrations such as the Ministry of Health, as detailed by Demócrata. María Fernández of the Ministry highlighted the department’s work on a multidisciplinary approach, pointing to the 2025–2028 Development Document of the Strategy for Chronic Care, which integrates liver health and will establish a specific working group next year, according to Demócrata.
Keep reading